SRC and cancer: These drugs have multiple targets including ASM and src family of kinases.49, 50 Indeed, a src family tyrosine kinase inhibitor, sorafenib has been shown to induce ferroptosis in cancer cells.21, 51 Identification of these targets and how they regulate ferroptosis will be the focus of future investigations.